BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 34779655)

  • 1. Association of Race and Ethnicity and Anticoagulation in Patients With Atrial Fibrillation Dually Enrolled in Veterans Health Administration and Medicare: Effects of Medicare Part D on Prescribing Disparities.
    Essien UR; Kim N; Magnani JW; Good CB; Litam TMA; Hausmann LRM; Mor MK; Gellad WF; Fine MJ
    Circ Cardiovasc Qual Outcomes; 2022 Feb; 15(2):e008389. PubMed ID: 34779655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Race/Ethnicity and Sex-Related Differences in Direct Oral Anticoagulant Initiation in Newly Diagnosed Atrial Fibrillation: A Retrospective Study of Medicare Data.
    Essien UR; Magnani JW; Chen N; Gellad WF; Fine MJ; Hernandez I
    J Natl Med Assoc; 2020 Feb; 112(1):103-108. PubMed ID: 32035755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disparities in Anticoagulant Therapy Initiation for Incident Atrial Fibrillation by Race/Ethnicity Among Patients in the Veterans Health Administration System.
    Essien UR; Kim N; Hausmann LRM; Mor MK; Good CB; Magnani JW; Litam TMA; Gellad WF; Fine MJ
    JAMA Netw Open; 2021 Jul; 4(7):e2114234. PubMed ID: 34319358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial and Ethnic Disparities in Initiation of Direct Oral Anticoagulants Among Medicare Beneficiaries.
    Reynolds KR; Khosrow-Khavar F; Dave CV
    JAMA Netw Open; 2024 May; 7(5):e249465. PubMed ID: 38709533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Race/Ethnicity With Oral Anticoagulant Use in Patients With Atrial Fibrillation: Findings From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II.
    Essien UR; Holmes DN; Jackson LR; Fonarow GC; Mahaffey KW; Reiffel JA; Steinberg BA; Allen LA; Chan PS; Freeman JV; Blanco RG; Pieper KS; Piccini JP; Peterson ED; Singer DE
    JAMA Cardiol; 2018 Dec; 3(12):1174-1182. PubMed ID: 30484833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Neighborhood Disadvantage and Anticoagulation for Patients with Atrial Fibrillation in the Veterans Health Administration: the REACH-AF Study.
    McDermott A; Kim N; Hausmann LRM; Magnani JW; Good CB; Litam TMA; Mor MK; Omole TD; Gellad WF; Fine MJ; Essien UR
    J Gen Intern Med; 2023 Mar; 38(4):848-856. PubMed ID: 36151447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Facility-Level Variation in Racial Disparities in Anticoagulation for Atrial Fibrillation: The REACH-AF Study.
    Essien UR; Kim N; Hausmann LRM; Washington DL; Mor MK; Gellad WF; Fine MJ
    J Gen Intern Med; 2024 May; 39(7):1122-1126. PubMed ID: 38308154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing total medical expenditure between patients receiving direct oral anticoagulants vs warfarin for the treatment of atrial fibrillation: evidence from VA-Medicare dual enrollees.
    Wong ES; Done N; Zhao M; Woolley AB; Prentice JC; Mull HJ
    J Manag Care Spec Pharm; 2021 Aug; 27(8):1056-1066. PubMed ID: 34337995
    [No Abstract]   [Full Text] [Related]  

  • 9. Anticoagulant Prescribing for Non-Valvular Atrial Fibrillation in the Veterans Health Administration.
    Rose AJ; Goldberg R; McManus DD; Kapoor A; Wang V; Liu W; Yu H
    J Am Heart Assoc; 2019 Sep; 8(17):e012646. PubMed ID: 31441364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population Dementia Incidence and Direct Oral Anticoagulant Use in a Representative Population With Atrial Fibrillation.
    Thunell J; Wood K; Wharton W; Joyce G; Ferido P; Zissimopoulos J
    Neurology; 2024 Jul; 103(1):e209568. PubMed ID: 38857466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guideline-concordant initiation of oral anticoagulant therapy for stroke prevention in older veterans with atrial fibrillation eligible for Medicare Part D.
    Done N; Roy AM; Yuan Y; Pizer SD; Rose AJ; Prentice JC
    Health Serv Res; 2019 Feb; 54(1):128-138. PubMed ID: 30417341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct Oral Anticoagulants and Warfarin for Atrial Fibrillation Treatment: Rural and Urban Trends in Medicare Beneficiaries.
    Norby FL; Lutsey PL; Shippee ND; Chen LY; Henning-Smith C; Alonso A; Walker RF; Folsom AR
    Am J Cardiovasc Drugs; 2022 Mar; 22(2):207-217. PubMed ID: 34633646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in Anticoagulant Utilization Among United States Nursing Home Residents With Atrial Fibrillation From 2011 to 2016.
    Alcusky M; McManus DD; Hume AL; Fisher M; Tjia J; Lapane KL
    J Am Heart Assoc; 2019 May; 8(9):e012023. PubMed ID: 31046504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial/Ethnic Disparities in Atrial Fibrillation Treatment and Outcomes among Dialysis Patients in the United States.
    Waddy SP; Solomon AJ; Becerra AZ; Ward JB; Chan KE; Fwu CW; Norton JM; Eggers PW; Abbott KC; Kimmel PL
    J Am Soc Nephrol; 2020 Mar; 31(3):637-649. PubMed ID: 32079604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial and Sex Disparities in Anticoagulation After Electrical Cardioversion for Atrial Fibrillation and Flutter.
    Mentias A; Nakhla S; Desai MY; Wazni O; Menon V; Kapadia S; Vaughan Sarrazin M
    J Am Heart Assoc; 2021 Sep; 10(17):e021674. PubMed ID: 34431314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disparities and Temporal Trends in the Use of Anticoagulation in Patients With Ischemic Stroke and Atrial Fibrillation.
    Sur NB; Wang K; Di Tullio MR; Gutierrez CM; Dong C; Koch S; Gardener H; García-Rivera EJ; Zevallos JC; Burgin WS; Rose DZ; Goldberger JJ; Romano JG; Sacco RL; Rundek T
    Stroke; 2019 Jun; 50(6):1452-1459. PubMed ID: 31084325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of real-world outcomes in patients with nonvalvular atrial fibrillation treated with direct oral anticoagulant agents or warfarin.
    Datar M; Crivera C; Rozjabek H; Abbass IM; Xu Y; Pasquale MK; Schein JR; Andrews GA
    Am J Health Syst Pharm; 2019 Feb; 76(5):275-285. PubMed ID: 30698654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in anticoagulant prescribing: a review of local policies in English primary care.
    Ho KH; van Hove M; Leng G
    BMC Health Serv Res; 2020 Apr; 20(1):279. PubMed ID: 32245380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation.
    Nazha B; Pandya B; Cohen J; Zhang M; Lopes RD; Garcia DA; Sherwood MW; Spyropoulos AC
    Circulation; 2018 Oct; 138(14):1402-1411. PubMed ID: 29794081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Frailty and Associations with Oral Anticoagulant Prescribing in Atrial Fibrillation.
    Sanghai SR; Liu W; Wang W; Rongali S; Orkaby AR; Saczynski JS; Rose AJ; Kapoor A; Li W; Yu H; McManus DD
    J Gen Intern Med; 2022 Mar; 37(4):730-736. PubMed ID: 33948795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.